Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivolac Cultures Corporation is a specialized biotechnology company focused on the development and manufacture of microbial starter cultures and ingredients for the dairy and fermented food industries. Founded in 1968, the company provides a wide range of lactic acid bacteria, probiotics, and biopreservatives used in the production of cheese, yogurt, and other cultured dairy products. Vivolac is recognized for its expertise in strain selection, fermentation technology, and customized culture programs designed to improve product texture, flavor, and shelf-life. In 2011, the company was acquired by the Kerry Group, integrating its microbial capabilities into Kerry's global food and beverage technology portfolio. Today, it continues to operate as a key brand within the industrial microbiology and nutrition sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivolac Cultures Corporation.